Companies /Healthcare

Insulet Corporation

NASDAQ: PODD Medical Devices
$143.41
â–² $0.03 (+0.02%) today
Markets closed · 5:59pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$9.9B
P/E Ratio
26.9
Profit Margin
12.3%
Revenue (TTM)
$3.1B
EPS (TTM)
$5.34
52-Week Range
$126 – $355
Street Target
$171.91

About Insulet

Insulet Corporation specializes in innovative insulin delivery systems for those with insulin-dependent diabetes. Its flagship Omnipod platform offers a range of products, including the Omnipod 5, which integrates with continuous glucose monitors for automated insulin delivery, and the Omnipod DASH, a smartphone-like device managing insulin delivery with ease. Additionally, the Omnipod GO provides a simple, wearable insulin delivery option. With a focus on accessibility, Insulet sells its products globally through distributors, pharmacies, and direct sales, aiming to improve the lives of people with diabetes around the world. Founded in 2000, the company is based in Acton, Massachusetts.

PODD Coverage